Why Relay Therapeutics (RLAY) Stock Is Down 17% Today
Why Relay Therapeutics (RLAY) Stock Is Down 17% Today
Relay Therapeutics Inc (NASDAQ:RLAY) shares are trading lower by 17.8% to $7.40 during Wednesday's session after the company priced its $200 million offering.
Relay Therapeutics Inc（納斯達克股票代碼：RLAY）股價在週三的交易中下跌17.8％，至7.40美元，此前該公司對2億美元的發行進行了定價。
The offering of 28.57 million shares of common stock at $7.00 per share is expected to raise approximately $200 million before fees. The company has also granted underwriters a 30-day option to buy an additional 4.29 million shares. Goldman Sachs, TD Cowen, Stifel and BofA Securities are leading the offering, with Raymond James as co-manager.
以每股7.00美元的價格發行2857萬股普通股預計將籌集約2億美元（不計費用）。該公司還授予承銷商30天的期權，可以額外購買429萬股股票。高盛、道明考恩、Stifel和美銀證券牽頭髮行，雷蒙德·詹姆斯擔任聯席經理。
The offering is expected to close around September 12, pending standard closing conditions.
此次發行預計將於9月12日左右結束，但尚待標準成交條件。
Read Also: 'Not A Slam Dunk For Harris, But The Chances Of A Trump Victory Have Slipped:' Investors, Markets Adjust Positions After Presidential Debate
另請閱讀：「對賀錦麗來說不是灌籃，但特朗普獲勝的機會已經減弱：」 投資者，市場在總統辯論後調整頭寸
Should I Sell My RLAY Stock?
我應該賣掉我的 RLAY 股票嗎？
When deciding to hold on to or sell a stock, investors should consider their time horizon, unrealized gains and total return.
在決定持有或出售股票時，投資者應考慮其時間範圍、未實現收益和總回報。
Shares of Relay Therapeutics have decreased by 20.97% in the past year. An investor who bought shares of Relay Therapeutics at the beginning of the year would take a loss of $4.36 per share if they sold it today. The stock has risen 14.33% over the past month, meaning an investor who bought shares on Aug. 1 would see a capital loss of $0.13.
在過去的一年中，Relay Therapeutics的股價下降了20.97％。年初購買了Relay Therapeutics股票的投資者如果今天出售，則每股虧損4.36美元。該股在過去一個月中上漲了14.33％，這意味着在8月1日購買股票的投資者將遭受0.13美元的資本損失。
Relay Therapeutics shares have an all-time high of $37.41, representing 398.8% upside from current levels.
Relay Therapeutics的股價創歷史新高，爲37.41美元，較目前的水平上漲了398.8％。
Investors may also consider market dynamics. The Relative Strength Index can be used to indicate whether a stock is overbought or oversold. Relay Therapeutics stock currently has an RSI of 75.61, indicating overbought conditions.
投資者也可以考慮市場動態。相對強弱指數可用於表明股票是超買還是超賣。Relay Therapeutics股票目前的相對強弱指數爲75.61，這表明存在超買情況。
For access to advanced charting and analysis tools and stock data, check out Benzinga PRO. Try it for free.
要訪問高級製圖和分析工具以及股票數據，請查看 Benzinga PRO。免費試用。
RLAY has a 52-week high of $12.14 and a 52-week low of $5.70.
RLAY的52周高點爲12.14美元，52周低點爲5.70美元。
譯文內容由第三人軟體翻譯。
